Turning Point Therapeutics, Inc.

UBS Group AG

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/10/2022

Shares

71,942

Value ($000)

5,413

Weight

0.0%

2019 Q4 - 2022 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/10/2022	5,413	0.0%	71,942	6/30/2022
2022 Q1	5/16/2022	1,993	0.0%	74,233	3/31/2022
2021 Q4	2/14/2022	5,755	0.0%	120,638	12/31/2021
2021 Q3	11/15/2021	2,468	0.0%	37,143	9/30/2021
2021 Q2	8/13/2021	643	0.0%	8,249	6/30/2021
2021 Q1	5/12/2021	3,953	0.0%	41,792	3/31/2021
2020 Q4	2/11/2021	96	0.0%	786	12/31/2020
2020 Q3	11/12/2020	184	0.0%	2,105	9/30/2020
2020 Q2	7/31/2020	87	0.0%	1,342	6/30/2020
2020 Q1	5/1/2020	283	0.0%	6,352	3/31/2020
2019 Q4	2/14/2020	1,269	0.0%	20,375	12/31/2019